Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).

Source:http://linkedlifedata.com/resource/pubmed/id/16432855

Download in:

View as

General Info

PMID
16432855